Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.

Vincenza Conteduca,Giorgia Gurioli,Lorena Rossi, Emanuela Scarpi,Cristian Lolli,Giuseppe Schepisi,Alberto Farolfi,Delia De Lisi,Valentina Gallà,Salvatore Luca Burgio,Cecilia Menna,Andrea Amadori,Lorena Losi,Dino Amadori,Maria Paola Costi,Ugo De Giorgi

BMC cancer（2018）

引用 12|浏览40

暂无评分

摘要

The FOLFOX-4 regimen would seem to obtain similar survival rates to those of standard therapy with topotecan in platinum-resistant ovarian cancer. Further randomized trials are warranted to confirm our findings.

查看译文

关键词

FOLFOX-4,Fluorouracil,Topotecan,Ovarian cancer,Platinum resistance,Survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要